Maria Inmaculada
Heras Fernando
Asociado Ciencias de la Salud
Mar
Tormo Díaz
Publications by the researcher in collaboration with Mar Tormo Díaz (9)
2020
-
UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy
Leukemia, Vol. 34, Núm. 11, pp. 2925-2933
2015
-
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML
American Journal of Clinical Pathology, Vol. 144, Núm. 3, pp. 484-492
-
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
Blood Cancer Journal, Vol. 5, pp. e352
-
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature
Oncotarget, Vol. 6, Núm. 31, pp. 31613-31627
2013
-
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
Leukemia, Vol. 27, Núm. 11, pp. 2157-2164
2010
-
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group
Haematologica, Vol. 95, Núm. 4, pp. 589-596
2009
-
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy
Leukemia, Vol. 23, Núm. 3, pp. 486-491
2008
-
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the programa Español de tratamiento en hematología pediatric-based protocol ALL-96
Journal of Clinical Oncology, Vol. 26, Núm. 11, pp. 1843-1849